Reports in Thyroid Research

Department of Anatomy, Cell Biology and Physiological Sciences, American University of Beirut, Beirut 1107, Lebanon

Publications

• Mini Review   
  The Dual Role of Glucagon-like Peptide-1 (GLP-1) Receptor Agonists in Prostate Cancer: From Diabetes to Oncology
  Author(s): Abdulrahman David*
  
  Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) are widely used in the management of type 2 diabetes due to their glucose-lowering effects and favorable safety profile. However, emerging evidence suggests that GLP-1 RAs may also have a dual role in prostate cancer, with both beneficial and potentially harmful effects. This article provides an overview of the current understanding of the dual role of GLP-1 RAs in prostate cancer, highlighting their potential as a therapeutic target in oncology... Read More»
  DOI: 10.37421/2684-4273.2024.8.59

  Abstract HTML PDF